Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.Albuquerque,K.; Giangreco,D.; Morrison,C.; Siddiqui,M.; Sinacore,J.; Potkul,R.; Roeske,J.International journal of radiation oncology, biology, physics 2011 ;79(4):1043-1047
Hepatic resection for recurrent metastatic ovarian cancer.Abood,G.; Bowen,M.; Potkul,R.; Aranha,G.; Shoup,M.AMERICAN JOURNAL OF SURGERY 2008 ;195(3):370-373
FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast.Omeroglu,G.; Ersahin,C.; Potkul,R. K.; Booth,C. N.DIAGNOSTIC CYTOPATHOLOGY 2007 ;35(8):508-511
Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia.Ersahin,C.; Omeroglu,G.; Potkul,R. K.; Salhadar,A.GYNECOLOGIC ONCOLOGY 2007 ;106(1):259-261
Mesonephric adenocarcinoma of the vagina with a 3-year follow-up.Ersahin,C.; Huang,M.; Potkul,R. K.; Hammadeh,R.; Salhadar,A.GYNECOLOGIC ONCOLOGY 2005 ;99(3):757-760
Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer.Albuquerque,K. V.; Singla,R.; Potkul,R. K.; Smith,D. M.; Creech,S.; Lo,S.; Emami,B.GYNECOLOGIC ONCOLOGY 2005 ;96(3):701-704